Timber Pharmaceuticals, Inc. (AMEX:TMBR) went up by 6.45% from its latest closing price when compared to the 1-year high value of $12.60 and move down -536.36%, while TMBR stocks collected -2.94% of loss with the last five trading sessions. Press Release reported on 07/22/20 that Timber Pharmaceuticals Announces European Patent Office Intends to Grant Patent for BPX-01 and BPX-04
Timber Pharmaceuticals, Inc. (AMEX:TMBR) Worth an Investment?
Timber Pharmaceuticals, Inc. (AMEX: TMBR) The 36 Months beta value for TMBR stocks is at 0.43, while 0 of the analysts out of 1 who provided ratings for Timber Pharmaceuticals, Inc. stocks as a “buy” while 0 as overweight, 1 rated it as hold and 0 as sell. The average price we get from analysts is $12.00 which is -$1.98 below current price. TMBR currently has a short float of 10.99% and public float of 3.81M with average trading volume of 987.11K shares.
TMBR Market Performance
TMBR stocks went down by -2.94% for the week, with the monthly drop of -10.00% and a quarterly performance of -47.54%, while its annual performance rate touched -56.58%. The simple moving average for the period of the last 20 days is -7.97% for TMBR stocks with the simple moving average of -49.92% for the last 200 days.
TMBR Stocks -17.69% Far from 50 Day Moving Average
After a stumble in the market that brought TMBR to its low price for the period of the last 52 weeks, Timber Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -84.29% of loss for the given period.
The stock volatility was left at 7.33%, however, within the period of a single month, the volatility rate increased by 9.68%, while the shares sank at the distance of -8.76% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -45.75% lower at the present time.
In the course of the last 5 trading sessions, TMBR went down by -2.94%, which changed the moving average for the period of 200 days to the total of -50.03% of losses for the stock in comparison to the 20-day moving average settled at $2.1420. In addition, Timber Pharmaceuticals, Inc. saw -61.08% in overturn over the period of a single year with a tendency to cut further losses.